London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
From linked in today.
Did you know that supercapacitors are playing a crucial role in advancing the field of medical devices? 💡
Supercapacitors showcase their effectiveness in medical applications through innovative instances like needle-free jet injections and remote respiratory monitoring devices.
Supercapacitors have a low ESR that delivers bursts of power which are needed in fast, large-volume medical devices. This makes it ideal as an energy storage solution for hand-held medical equipment.
Furthermore, their thin form factor fits easily inside the small drug delivery device.
CAP-XX Limited has worked with Spire Health and Portal Instruments to provide our ultra-thin prismatic and cylindrical supercapacitors for their medical devices. This perfectly exemplifies the power and versatility of these energy storage solutions
The company is back on a growth track, with a lower cost base and strengthened balance sheet post fund raise to invest in product launches and growth. The company looks to be turning around under the new CEO’s updated strategy.
Agree. Should see the sp back to placing price by the end of this year and then another raise next year before finally heading north of 0.1p in 2026 if all goes well and smoothly.
I’m hoping for 50% increase in my investment by end of 2026.
Never seen such a tight spread on these.
Currently 0.0851 to sell v 0.0856 to buy
Usually a very positive sign that MMs happy to make a fair market both ways
Current order backlog remains close to US$1m.
Trading on existing products remains strong and trial shipments of pre-samples of new product have recently commenced.
Administering Biologics
Chronic disease self-managed in the home with biologic-based therapies place the burden of drug administration on the patient and may lead to disease management anxiety, poor adherence and less than optimal outcomes. Treatment adherence for biologics are estimated to be 40% to 70% depending upon the indication [CDC, 2013; FDA 2016]. Patient anxiety can be compounded by the use of needle-based drug delivery devices to administer these medicines.
Needle anxiety, which is very different from needle-phobia, is a real concern. For many, having needles in the home is not desirable. Aside from the associated stigma around needle use, concerns include an innate dislike of needles, the inconvenience of disposing of needles and, safety around needle use which is especially worrisome when children live in the home.
Patients that switch to biologics want to administer their therapy successfully. Current modes of injection administration can cause patient anxiety and can be uncomfortable, especially if it requires the needle to be in the patient for 10-30 seconds to administer the complete dose. Some patients may even refuse a therapy if it requires a needle-based self-injection.
Portal Instruments uses multiple ultra-power-dense CAP-XX GS230F supercapacitors to deliver hundreds of watts of output power to drive the high-speed, concentrated injection in its compact handheld device. CAP-XX’s industry-leading power density enables the device’s small, easy-to-use form factor and allows the device to operate from a compact, industry-standard rechargeable battery which recharges the supercapacitors before every injection.
Spire Health, the leading provider of respiratory remote patient monitoring (RPM), has selected the CAP-XX supercap to provide the peak power needed to deliver respiratory and pulse rate monitoring for pulmonary patients in the company’s new Health Tag garment-adhered sensor. The company’s original Health Tags used CAP-XX supercapacitors to deliver wellness alerts to consumers. The new Health Tag’s core focus is now healthcare, where the CAP-XX supercapacitors are used to notify a patient’s care team of changes in their health in an effort to enable early interventions and prevent hospital admissions.
Raise for what exactly?
CPX will be making big strides this year and that will be reflected in the share price in 2024.
Lars is most definitely being very cautious in his outlook, better to under promise and over perform.
Current MCAP will be surpassed easily.
Fwiw there were plenty of negative naysayers 12 months ago on a company called Cornerstone that collapsed and needed emergency fund raise (down from 60p to just 6p in no time due to poor financial management by the CEO - sound familiar?) I piled in well below 10p, currently trading to 40p today following appointment of new CEO.
CPX will almost certainly be doing something similar over next 6-12 months.
'Lars is most definitely being very cautious in his outlook, better to under promise and over perform.'
This is without doubt one of the funniest posts I've read on any of these lse bbs for many years. Where have you been for the past year or so?
Sorry newuncle but you're posting utter bs
Sp hopefully back to .1p by end of 2025 and then hopefully higher in 2026. Let's be realistic.
Roger you keep mentioning 2026 like you desperately want it to stay low to average down.
So obvious
Trax,
Its obvious why Roger is posting here, enough said. There will also be his type on BBs, no matter what. Their ego's are as big as a house and they won't stop once they have their hook line, Roger's is Lars comment about 2026 breakeven. I could easily flame that but what's the point, wasted time on a person I do not know or care for.
Funny this year was supposed to be the magical break even year what happend to that 🤔
Of course there always will be.
He is a troll that sits on the fence to Instill doubt
I know
Trax,
Can't quite bring himself to go full bear so he goes about 80/20 bearish/ v bull just in case the price moves positive. Reminds me of someone else we know.
Roger why do you think it will be 1p in 2025 , give us a bit more details and why not in a few weeks /months
Think he said 0.1p actually...
So he is "forecasting" +25% over 18 months......I think we can all safely say that is LOL funny and utter BS
Multi bugger 0.1 lol this guy just came out of the cave
There are mean bears and there are bad bears and then there are harmless teddy bears......
1p most likely due to consolidation